BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Colling ME, Tourdot BE, Kanthi Y. Inflammation, Infection and Venous Thromboembolism. Circ Res 2021;128:2017-36. [PMID: 34110909 DOI: 10.1161/CIRCRESAHA.121.318225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen G, Liang Y, Wang D, Zhang F, Huang R, Ge Y, Liao C, Hao X, Chen Y, Han J, Yang X, Duan Y. Polysaccharide extracted from Morchella esculenta inhibits carrageenan-induced thrombosis in mice. Journal of Functional Foods 2022;97:105235. [DOI: 10.1016/j.jff.2022.105235] [Reference Citation Analysis]
2 Knight R, Walker V, Ip S, Cooper JA, Bolton T, Keene S, Denholm R, Akbari A, Abbasizanjani H, Torabi F, Omigie E, Hollings S, North TL, Toms R, Jiang X, Angelantonio ED, Denaxas S, Thygesen JH, Tomlinson C, Bray B, Smith CJ, Barber M, Khunti K, Davey Smith G, Chaturvedi N, Sudlow C, Whiteley WN, Wood AM, Sterne JAC; CVD-COVID-UK/COVID-IMPACT Consortium and the Longitudinal Health and Wellbeing COVID-19 National Core Study. Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales. Circulation 2022;146:892-906. [PMID: 36121907 DOI: 10.1161/CIRCULATIONAHA.122.060785] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Dix C, Zeller J, Stevens H, Eisenhardt SU, Shing KSCT, Nero TL, Morton CJ, Parker MW, Peter K, Mcfadyen JD. C-reactive protein, immunothrombosis and venous thromboembolism. Front Immunol 2022;13:1002652. [DOI: 10.3389/fimmu.2022.1002652] [Reference Citation Analysis]
4 Leung C, Su L, Simões E Silva AC. Better healthcare can reduce the risk of COVID-19 in-hospital post-partum maternal death: evidence from Brazil. Int J Epidemiol 2022:dyac157. [PMID: 35947762 DOI: 10.1093/ije/dyac157] [Reference Citation Analysis]
5 Manoharan R, Kore RA, Mehta JL. Mesenchymal stem cell treatment for hyperactive immune response in patients with COVID-19. Immunotherapy 2022. [PMID: 35855633 DOI: 10.2217/imt-2021-0245] [Reference Citation Analysis]
6 Kuijpers MJE, Heemskerk JWM, Jurk K. Molecular Mechanisms of Hemostasis, Thrombosis and Thrombo-Inflammation. Int J Mol Sci 2022;23:5825. [PMID: 35628635 DOI: 10.3390/ijms23105825] [Reference Citation Analysis]
7 Scheres LJJ, Hylckama Vlieg A, Cannegieter SC. Sex‐specific aspects of venous thromboembolism: What is new and what is next? Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12722] [Reference Citation Analysis]
8 Schwartz GG, Ballantyne CM. Existing and emerging strategies to lower Lipoprotein(a). Atherosclerosis 2022;349:110-22. [DOI: 10.1016/j.atherosclerosis.2022.04.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
9 Gupta A, Al-Tamimi AO, Halwani R, Alsaidi H, Kannan M, Ahmad F. Lipocalin-2, S100A8/A9, and cystatin C: Potential predictive biomarkers of cardiovascular complications in COVID-19. Exp Biol Med (Maywood) 2022;:15353702221091990. [PMID: 35466734 DOI: 10.1177/15353702221091990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Pilard M, Ollivier EL, Gourdou-latyszenok V, Couturaud F, Lemarié CA. Endothelial Cell Phenotype, a Major Determinant of Venous Thrombo-Inflammation. Front Cardiovasc Med 2022;9:864735. [DOI: 10.3389/fcvm.2022.864735] [Reference Citation Analysis]
11 Otasevic V, Mihaljevic B, Milic N, Stanisavljevic D, Vukovic V, Tomic K, Fareed J, Antic D. Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients. Thromb J 2022;20:20. [PMID: 35439998 DOI: 10.1186/s12959-022-00381-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kantarcioglu B, Darki A, Siddiqui F, Hoppensteadt D, Lewis J, Krämer R, Adiguzel C, Fareed J. The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients. Clin Appl Thromb Hemost 2022;28:107602962210917. [DOI: 10.1177/10760296221091770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Sun Y, Langer HF. Platelets, Thromboinflammation and Neurovascular Disease. Front Immunol 2022;13:843404. [DOI: 10.3389/fimmu.2022.843404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Angriman F, Rosella LC, Lawler PR, Ko DT, Wunsch H, Scales DC. Sepsis hospitalization and risk of subsequent cardiovascular events in adults: a population-based matched cohort study. Intensive Care Med 2022. [PMID: 35142896 DOI: 10.1007/s00134-022-06634-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Alnima T, Mulder MMG, van Bussel BCT, Ten Cate H. COVID-19 Coagulopathy: From Pathogenesis to Treatment. Acta Haematol 2022;145:282-96. [PMID: 35499460 DOI: 10.1159/000522498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Knight JS, Kanthi Y. Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome. Semin Immunopathol 2022. [PMID: 35122116 DOI: 10.1007/s00281-022-00916-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
17 Pan J, Zhu R, Lin J, Li X, Xia J. Incidence and risk factors for venous thromboembolism during an acute attack in patients with neuromyelitis optica spectrum disorders. Mult Scler Relat Disord 2022;58:103513. [PMID: 35038646 DOI: 10.1016/j.msard.2022.103513] [Reference Citation Analysis]
18 Wang Z, Zhou Q, Liu H, Zhang J, Zhu Z, Wu J, Chen X, Liu Y. Association Between Monocyte Count and Preoperative Deep Venous Thrombosis in Older Patients with hip Fracture: A Retrospective Study. Clin Appl Thromb Hemost 2022;28:10760296221100806. [PMID: 35538853 DOI: 10.1177/10760296221100806] [Reference Citation Analysis]
19 Kantarcioglu B, Darki A, Siddiqui F, Krupa E, Vural M, Kacmaz M, Hoppensteadt D, Iqbal O, Jeske W, Walenga J, Adiguzel C, Fareed J. Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism. Clin Appl Thromb Hemost 2022;28:10760296221104801. [PMID: 35733366 DOI: 10.1177/10760296221104801] [Reference Citation Analysis]
20 Toldo S, Mezzaroma E, Buckley LF, Potere N, Di Nisio M, Biondi-Zoccai G, Van Tassell BW, Abbate A. Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacol Ther 2021;236:108053. [PMID: 34906598 DOI: 10.1016/j.pharmthera.2021.108053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
21 Ren C, Li M, Ma T, Xu YB, Li Z, Xue HZ, Wang Q, Lu Y, Sun L, Zhang K. Nonspecific ST-Segment and T-Wave (NS-STT) on Electrocardiogram is Associated with Increasing the Incidence of Perioperative Deep Vein Thrombosis in Patients with Lower Extremity Fracture Under 75 Years Old. Int J Gen Med 2021;14:8631-41. [PMID: 34866930 DOI: 10.2147/IJGM.S335243] [Reference Citation Analysis]
22 Groarke EM, Dulau-Florea AE, Kanthi Y. Thrombotic manifestations of VEXAS syndrome. Semin Hematol 2021;58:230-8. [PMID: 34802545 DOI: 10.1053/j.seminhematol.2021.10.006] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Leeper NJ, Hamburg NM. Peripheral Vascular Disease in 2021. Circ Res 2021;128:1803-4. [PMID: 34110903 DOI: 10.1161/CIRCRESAHA.121.319562] [Cited by in F6Publishing: 2] [Reference Citation Analysis]